1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Salvage therapy classified by histologic grade, ADC and rCBV values
Salvage SurgeryAdditional Chemotherapy
Grade II6 (4.8%)1 (0.8%)
Grade III2 (1.6%)2 (1.6%)
Grade IV11 (8.7%)15 (12%)
Total19 (15.1%)18 (14.4%)
rCBV ≥ 5.1958 (6.3%)11 (8.7%)
rCBV < 5.19511 (8.7%)7 (5.7%)
Total19 (15.1%)18 (14.4%)
ADC < 0.799 × 10−3 mm2/s10 (8%)12 (9.6%)
ADC ≥ 0.799 × 10−3 mm2/s9 (7.1%)6 (4.8%)
Total19 (15.1%)18 (14.4%)